Analysts and insiders getting more bullish about Provention Bio (PRVB) and another strong rally for Atomera (ATOM) as Russell 2000 rebalance approaches
The week started off with a flurry of data and developments from Cue Biopharma (CUE) and Provention Bio (PRVB), along with a rally for Atomera (ATOM)
Russell 2000 Index annual rebalance list to be announced this week and likely includes three of our active recommendations.
Provention Bio (PRVB) closes a deal with high-quality life sciences investors. Then, insiders get back to buying. All while the market pivots to “risk-off”
Provention Bio (PRVB) prints a deal with top life sciences investors and it’s Cue Biopharma’s (CUE) turn to rally above key resistance levels
Small caps got back to rallying and management teams hit the conference circuit, including Provention Bio (PRVB) and Resonant Inc (RESN).